Diethylstilbestrol

Publication Title: 
British Journal of Cancer
Author(s): 
Blackburn, E. K.
Publication Title: 
The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry

OBJECTIVES: We explored whether in utero DES exposure has produced consistent findings with regard to an increased risk of psychiatric disorders. METHODS: We reviewed systematically the epidemiological studies investigating a possible association between prenatal DES exposure and risk of psychiatric disorders. RESULTS: We identified 10 relevant studies reporting the psychiatric outcome of offspring with a history of in utero DES exposure compared to a control group.

Author(s): 
Kebir, Oussama
Krebs, Marie-Odile
Publication Title: 
Journal of Ethnopharmacology

The rhizomes of Curculigo orchioides Gaertn. (Amaryllidacea) is an important Ayurvedic as well as Unani drug. It is present in several drug formulations used in the treatment of menorrhagia and other gynecological problems. In this study, we conducted a comparative study of estrogenic activity of alcoholic extract of Curculigo orchioides with diethylstilbestrol in bilaterally ovariectomized young albino rats.

Author(s): 
Vijayanarayana, K.
Rodrigues, Rashmi S.
Chandrashekhar, K. S.
Subrahmanyam, E. V. S.
Publication Title: 
The Journal of Pharmacology and Experimental Therapeutics

Prenatal exposure to diethylstilbestrol (DES) is known to cause altered immune functions and increased susceptibility to autoimmune disease in humans. In the current study, we investigated the effect of prenatal exposure to DES on thymocyte differentiation involving apoptotic pathways. Prenatal DES exposure caused thymic atrophy, apoptosis, and up-regulation of Fas and Fas ligand (FasL) expression in thymocytes.

Author(s): 
Singh, Narendra P.
Singh, Udai P.
Nagarkatti, Prakash S.
Nagarkatti, Mitzi
Subscribe to RSS - Diethylstilbestrol